P&K Skin Research Center Co. Ltd Cash Flow Conversion Efficiency
P&K Skin Research Center Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, P&K Skin Research Center Co. Ltd (347740) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.70 Billion ≈ $1.15 Million USD) by net assets (₩81.39 Billion ≈ $55.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of P&K Skin Research Center Co. Ltd (2018–2024)
Cash flow conversion efficiency of P&K Skin Research Center Co. Ltd from 2018 to 2024. This chart illustrates how P&K Skin Research Center Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for P&K Skin Research Center Co. Ltd for real-time trading data and today's change.
P&K Skin Research Center Co. Ltd Cash Flow Conversion Ratio Explained
P&K Skin Research Center Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
P&K Skin Research Center Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of P&K Skin Research Center Co. Ltd ranked by their cash flow conversion efficiency. Also see 347740 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ERREDUE S.P.A.
F:Z9H
|
N/A |
|
RYTHM, Inc.
NASDAQ:RYM
|
0.221x |
|
Wolford Aktiengesellschaft
VI:WOL
|
0.044x |
|
Seondo Electric Co., Ltd.
KO:007610
|
-0.100x |
|
HC Group Inc
STU:HCI
|
0.125x |
|
Novacyt
PA:ALNOV
|
-0.141x |
|
Paru Co. Ltd
KQ:043200
|
-0.010x |
|
Royal Orchid Hotel (Thailand) Public Company Limited
BK:ROH
|
-0.003x |
Annual Cash Flow Conversion Efficiency for P&K Skin Research Center Co. Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of P&K Skin Research Center Co. Ltd from 2018 to 2024. Review P&K Skin Research Center Co. Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩76.94 Billion ≈ $52.14 Million |
₩9.03 Billion ≈ $6.12 Million |
0.117x | +57.07% |
| 2023-12-31 | ₩74.24 Billion ≈ $50.31 Million |
₩5.55 Billion ≈ $3.76 Million |
0.075x | -29.50% |
| 2022-12-31 | ₩70.81 Billion ≈ $47.98 Million |
₩7.51 Billion ≈ $5.09 Million |
0.106x | -13.13% |
| 2021-12-31 | ₩63.07 Billion ≈ $42.74 Million |
₩7.70 Billion ≈ $5.22 Million |
0.122x | -21.66% |
| 2020-12-31 | ₩55.63 Billion ≈ $37.70 Million |
₩8.67 Billion ≈ $5.87 Million |
0.156x | -41.24% |
| 2019-12-31 | ₩24.50 Billion ≈ $16.60 Million |
₩6.49 Billion ≈ $4.40 Million |
0.265x | -0.76% |
| 2018-12-31 | ₩15.96 Billion ≈ $10.81 Million |
₩4.26 Billion ≈ $2.89 Million |
0.267x | -- |
About P&K Skin Research Center Co. Ltd
P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vi… Read more